October 26, 2022
A federal judge on Wednesday gave CVS Pharmacy, Walgreens and Walmart a temporary reprieve from business practice requirements he imposed following a trial that found the pharmacy chains liable for problems associated with prescription painkiller addiction in two Ohio counties.
October 18, 2022
New Mexico's attorney general's office closed out an opioid bench trial against Walgreens on Tuesday with a declaration to the judge that the pharmacy giant has "made it easy for you with its admissions" at trial about how it distributed and dispensed the powerful narcotics.
October 12, 2022
Lead plaintiffs attorneys in multidistrict opioid litigation on Wednesday lambasted hundreds of local governments that are challenging a special fund for attorney fees, telling the Sixth Circuit that they've incurred "staggering" costs and that the challenge belongs in the dustbin.
October 11, 2022
A Cleveland federal judge overseeing thousands of lawsuits against drug companies said Tuesday that he would not halt trial preparations involving a southwestern Ohio county and several major pharmacy chains while the Sixth Circuit reviews the legal theory that led to a $650 million verdict in a similar case.
October 07, 2022
The hugely expensive effort to prepare a new bellwether trial in multidistrict opioid litigation should cease because the Sixth Circuit might soon reject the controversial legal theory undergirding opioid cases, according to major pharmacy chains.
October 05, 2022
The watchdog overseeing implementation of a verdict against CVS Pharmacy, Walgreens and Walmart in multidistrict opioid litigation has a conflict of interest because he's already a special master tasked with impartial dispute resolution in the MDL, the drugstore chains said on Wednesday.
October 04, 2022
The Cherokee Nation and Walmart have agreed to settle the tribe's suit over the retailer's alleged role in the opioid crisis, according to a notice filed Monday in Oklahoma state court.
September 30, 2022
A Cleveland federal judge presiding over thousands of opioid cases appointed his special master on Friday as administrator for abatement programs mandated as part of a judgment against CVS, Walgreens and Walmart, which were found liable to the tune of $650 million for contributing to prescription painkiller-related problems in two Ohio counties.
September 21, 2022
Months of talks with drug companies poised to become the next big targets in multidistrict opioid litigation haven't yielded major progress, and a "much more aggressive" approach is needed, one of the highest-ranking attorneys for MDL plaintiffs said Wednesday.
September 07, 2022
Three major pharmacy chains plan to challenge a federal judge's order to pay more than $650 million toward a plan to abate the opioid epidemic in two Northeast Ohio counties, according to notices of appeal filed Wednesday.